New rating for NorthX Biologics in International Sustainability Survey
We are proud to inform you that NorthX Biologics improved its score from bronze to silver in the International Sustainability Survey (EcoVadis) for the year 2022. We have also implemented ...
Advanced Biologics in Matfors and Beyond
Conference “Advanced Biologics in Matfors and Beyond” at NorthX Bio went to a big success! During a two day conference, a number of key stakeholders from the Swedish and Danish ...
Xintela and NorthX Biologics sign framework agreement for collaboration
Xintela and NorthX Biologics announce that they have signed a collaborative framework agreement to jointly accelerate the development of advanced therapeutics (ATMP) by leveraging the companies’ complementary skills and resources ...
Helena Strigård appointed as new CEO of rapidly expanding NorthX Biologics
The Board of NorthX Biologics (“NorthX”) has appointed Helena Strigård as the new CEO. She joins NorthX from her role as Director General for the Swedish life science industry organization, ...
Drug development of today and the future
What: SeminarWhere: Klara Strand, Klarabergsviadukten 90, StockholmWhen: 19th October We are organizing a seminar on “Drug development of Today and the Future” in collaboration with Abera Biosciences AB, Testa Center, RISE Research ...
Test on humans approaching for Swedish vaccine
Human testing approaching for Swedish vaccine (lakemedelsvarlden.se) (Swedish)
NorthX Biologics expansion
Today we can announce that we are expanding within the production of cell therapy, i.a. via partnership with Alder Therapeutics and that we are expanding with a second manufacturing facility ...
ATMP world tour 2022 topic #8 ’CDMO roles in ATMP development’.
“We welcome Dave Smith from Akron Bio and Ola Tuvesson from NorthX Biologics to present and discuss the critical functions of CMOs and their role in managing the challenges of adapting from traditional biologics to ATMPs.” LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:6936961483540938752
NorthX Biologics appoints industry veterans to its board of directors
Sweden-based NorthX Biologics which focuses on process development and GMP manufacture of advanced biological drugs, has announced the appointments of Lotta Ljungqvist, Richard Bergström, Mathias Uhlén and Lars Backsell to its ...